Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Tuesday afternoon. Here’s what investors should ...

Masimo ( ($MASI) ) has shared an update. On August 5, 2025, Masimo Corporation announced its financial results for the second quarter of 2025, ...

Masimo (Nasdaq: MASI) shares dipped after hours today on second-quarter results that came in ahead of the consensus forecast.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it ...

Discover insights from Masimo Corporation's Q2 2025 earnings call. Growth strategies, tariff mitigation, and EPS updates highlight a confident outlook.

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors ...